Does BREXPIPRAZOLE Cause Product dose omission issue? 193 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Product dose omission issue have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 1.5% of all adverse event reports for BREXPIPRAZOLE.
193
Reports of Product dose omission issue with BREXPIPRAZOLE
1.5%
of all BREXPIPRAZOLE reports
2
Deaths
10
Hospitalizations
How Dangerous Is Product dose omission issue From BREXPIPRAZOLE?
Of the 193 reports, 2 (1.0%) resulted in death, 10 (5.2%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which BREXPIPRAZOLE Alternatives Have Lower Product dose omission issue Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE